DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Modulation of Rhamm (CD168) for selective adipose tissue development

Abstract

Herein is described the methods and compositions for modulation of Rhamm, also known as CD 186, and its effects on wound repair, muscle differentiation, bone density and adipogeneisis through its ability to regulate mesenchymal stem cell differentiation. Compositions and methods are provided for blocking Rhamm function for selectively increasing subcutaneous, but not, visceral fat. Compositions and methods for modulating Rhamm in wound repair are also described.

Inventors:
;
Issue Date:
Research Org.:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1130537
Patent Number(s):
8715653
Application Number:
12/515,405
Assignee:
The Regents of the University of California (Oakland, CA)
Patent Classifications (CPCs):
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES
DOE Contract Number:  
AC02-05CH11231
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES

Citation Formats

Turley, Eva A, and Bissell, Mina J. Modulation of Rhamm (CD168) for selective adipose tissue development. United States: N. p., 2014. Web.
Turley, Eva A, & Bissell, Mina J. Modulation of Rhamm (CD168) for selective adipose tissue development. United States.
Turley, Eva A, and Bissell, Mina J. Tue . "Modulation of Rhamm (CD168) for selective adipose tissue development". United States. https://www.osti.gov/servlets/purl/1130537.
@article{osti_1130537,
title = {Modulation of Rhamm (CD168) for selective adipose tissue development},
author = {Turley, Eva A and Bissell, Mina J},
abstractNote = {Herein is described the methods and compositions for modulation of Rhamm, also known as CD 186, and its effects on wound repair, muscle differentiation, bone density and adipogeneisis through its ability to regulate mesenchymal stem cell differentiation. Compositions and methods are provided for blocking Rhamm function for selectively increasing subcutaneous, but not, visceral fat. Compositions and methods for modulating Rhamm in wound repair are also described.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Tue May 06 00:00:00 EDT 2014},
month = {Tue May 06 00:00:00 EDT 2014}
}

Works referenced in this record:

Signaling Properties of Hyaluronan Receptors
journal, February 2002


Hyaluronan: from extracellular glue to pericellular cue
journal, July 2004


Of Mice and Not Men: Differences between Mouse and Human Immunology
journal, February 2004


Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility
journal, June 1992


MAP kinases and cell migration
journal, September 2004


Rhamm Peptide Conjugates
patent-application, February 2004


CD44 Regulates Hematopoietic Progenitor Distribution, Granuloma Formation, and Tumorigenicity
journal, September 1997


The Hyaluronan Receptor RHAMM Regulates Extracellular-regulated Kinase
journal, May 1998


The future of wound healing: Pursuing surgical models in transgenic and knockout mice
journal, October 2004


RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: A different interpretation of redundancy
journal, December 2004


TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan.
journal, November 1993


Rhamm−/− fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair
journal, December 2006


PAI-1 expression is required for epithelial cell migration in two distinct phases of in vitro wound repair
journal, January 2004


Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages
journal, August 2006


Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
patent, January 2012


Hyaluronan and Homeostasis: A Balancing Act
journal, February 2002


Chronic liver injury, TGF-β, and cancer
journal, December 2001


Paracrine Regulation of Angiogenesis and Adipocyte Differentiation During In Vivo Adipogenesis
journal, October 2003


RHAMM Antagonist Antibodies
patent-application, September 2002


Fibroblasts require protein kinase C activation to respond to hyaluronan with increased locomotion
journal, June 2001


Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM.
journal, March 1995


Hyaluronan and Hyaluronan Synthases: Potential Therapeutic Targets in Cancer
journal, February 2005


Mesenchymal Bone Marrow Stem Cells More Effectively Stimulate Regeneration of Deep Burn Wounds than Embryonic Fibroblasts
journal, January 2003


Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates cell responses to growth factors
journal, February 1999


The influence of the microenvironment on the malignant phenotype
journal, August 2000


Hyaluronan receptor expression increases in fetal excisional skin wounds and correlates with fibroplasia
journal, July 1998


Tumor-associated Antigen RHAMM
patent-application, September 2003


Purification of a hyaluronate-binding protein fraction that modifies cell social behavior
journal, October 1982